German Billionaire Dietmar Hopp Backs CureVac Further
This article was originally published in The Pink Sheet Daily
Executive Summary
Billionaire Dietmar Hopp’s latest CureVac injection – €80 million ($105 million) – is the biggest private financing ever given to a German biotech and brings the total that his venture capital firm, dievini Hopp BioTech holding GmbH & Co, has injected into CureVac to €145 million ($191 million).